Benign intracranial hypertension associated to blood coagulation derangements

Thrombosis Journal

Volumn 4, Issue , 2006, Pages

  De Lucia, Domenico ^a   Napolitano, Marisanta ^a   Di Micco, Pierpaolo ^b,c   Niglio, Alferio ^a   Fontanella, Andrea ^b   Di Lorio, Giuseppe ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b Ospedale Buonconsiglio Fatebenefratelli   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ACETYLSALICYLIC ACID; ALANINE; ASPARTIC ACID; BLOOD CLOTTING FACTOR 5 LEIDEN; CARDIOLIPIN ANTIBODY; CYSTEINE; DIPEPTIDYL CARBOXYPEPTIDASE; FIBRINOPEPTIDE A; GLYCINE; ISOLEUCINE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN; THREONINE; TICLOPIDINE;

ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; BLOOD CLOTTING DISORDER; BODY HEIGHT; BODY MASS; CEREBRAL SINUS THROMBOSIS; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FISHER EXACT TEST; GENE MUTATION; GENETIC POLYMORPHISM; HIGH RISK POPULATION; HUMAN; HYPERCOAGULABILITY; INCIDENCE; INTRACRANIAL HYPERTENSION; MALE; PATHOGENESIS; PROTEIN BLOOD LEVEL; PROTEIN C DEFICIENCY; RISK FACTOR; STATISTICAL SIGNIFICANCE;

EID: 33846663096     PISSN: None     EISSN: 14779560     Source Type: Journal    
DOI: 10.1186/1477-9560-4-21     Document Type: Article

References (21)

1. Smith JL Whence Pseudotumor Cerebri ? J Clin Neuro-ophtalmol 1985 5 55-56
2. Sussmon J Leach M Greaves M Malie R Davies-Jones GA Potentially prothrombotic abnormalities of coagulation in benign intracranial hypertension J Neurol Neurosurg Psichiatry 1997 62 3 229-233
3. Grun L Vinker S Amitel M Amir T Bar-Dayen Y Levi Y Schoenfeld Y Pseudotumor cerebri in Systemic Lupus Erythematosus Gemin Arthritis Rheum 1995 25 2 103-108 10.1016/S0049-0172(95)80023-9
4. Furie B Furie CB Molecular and cellular biology of blood coagulation N Eng J Med 1992 326 12 800-806
5. Miletich JP Prescott SM White R Majerus PW Bovill EG Inherited predisposition to thrombosis Cell 1993 72 477-480 10.1016/ 0092-8674(93)90063-V 8440014
6. Dahlback B Physiological anticoagulation. Resistance to actived protein C and venous thromboembolism J Clin Invest 1994 94 923-927 295127 8083377
7. Margaglione M Brancaccio V Giuliani N D'Andrea G Cappucci G Iannaccone L Vecchione G Grandone E Di Minno G Increased risk of venous thrombosis in carriers of the prothrombin A20210 gene variant Ann Intern Med 1998 129 89-93 9669991
8. De Stefano V Leone G Mastrangelo S Tripodi A Rodeghiero F Costaman G Barbui T Finazzi G Bizzi B Mannucci PM Clinical manifestation and management of inherited trombophilia: Retrospective analysis and follow-up after diagnosis of 238 patients with congenital deficiency of antithrombin III, protein C, protein S Thromb Haemostas 1994 72 352-358
9. Ames PRJ Pyke S Lannaccone L Brancaccio V Antiphospholipid antibodies, haemostatic variables and thrombosis. A survey of 144 patients Thromb Haemost 1995 73 768-773 7482401
10. Hamsten A De Faire U Walldius G Dahlen G Szamosi A Landou C Blomback M Wiman B Plasminogen activator inhibitor in plasma: Risk factor for recurrent myocardial infarction Lancet 1987 8549 2 3-9 10.1016/ S0140-6736(87)93050-9
11. Vaughan DE Lazos SA Tong K Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells: A potential link between the renin-angiotensin system and thrombosis J Clin Invest 1995 95 995-1001 441432 7884001
12. Cambien F Poirier O Lecerf L Evans A Cambou J Arveilier D Luc G Bard JM Ricard S Tiret L Amouyet P Alhenc-Gelas F Soubrier F Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction Nature 1992 359 641-644 10.1038/ 359641a0 1328889
13. Margaglione M D'Andrea G D'addedda M Giuliani N Cappucci G Iannaccone L Vecchione G Grandone E Brancaccio V Di Minno G The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of che FV Leiden and the prothrombin A2010 mutations Thromb Haemost 1998 79 907-911 9609218
14. Malm J Laurell M Nilsson IM Dahlback B Thromboebolic disease. Critical evaluation of laboratory investigation Thromb Haemost 1992 68 1 7-13 1514176
15. Bertina RM Koeleman BPC Koester T Rosendaal FR Dirven RJ de Ronde H van der Valden PA Reitsma PH Mutation in blood coagulation factor V associated with resistance to activated protein C Nature 1994 369 64-67 10.1038/369064a0 8164741
16. Margaglione M Di Minno G Grandone E Celentano E Vecchione G Cappucci G Grilli M Mancini FP Postiglione A Panico S Mancini M Plasma lipoprotein(a) levels in subjects attending a metabolic ward: discrimination between individuals with and without a history of ischemic stroke Arterioscler Thromb Vasc Biol 1996 16 120-128 8548412
17. Rigat B Hubert C Corvol P Soubrier F PCR detection of the insertion/ deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase) Nucleic Acids Res 1992 20 1433 312213 1313972 10.1093/nar/20.6.1433-a
18. Armitage P Berry G Statistical Methods in Medical Research Oxford, UK: Blackwell 3 1994 292-301
19. Backhouse O Metcalfe T Goulding P Mc Evoy M Menage M Factor V Leiden mutation in association with idiophatic intracranial hypertension Br J Ophthalmol 1998 82 844 9924388
20. Glueck CJ Goldenberg N Golnik K Sieve L Wang P Idiopathic intracranial hypertension: Asscoaitions with thrombophilia and hypofibrinolysis in men Clin Appl Thromb Hemost 2005 11 441-448 10.1177/107602960501100411 16244770
21. Picillo U Marcialis MR Italiano G Antiphospholipid sindrome. Current knowledge and our experiences Int J Surg Sci 1999 6 118-125